Press Releases
- Prospectus relating to Active Biotech's rights issue published November 18, 2016 15:16 (CET)
- Active Biotech carries out rights issue November 11, 2016 19:13 (CET)
- Active Biotech AB Interim report January - September 2016 November 11, 2016 19:00 (CET)
- Active Biotech and NeoTX enter into a partnership for the development and commercialization of ANYARA for immuno-oncology October 26, 2016 08:35 (CEST)
- Active Biotech and NeoTX enter into a partnership for the development and commercialization of ANYARA for immuno-oncology October 26, 2016 08:30 (CEST)
- Active Biotech postpone publication of the interim report October 26, 2016 08:27 (CEST)
- Active Biotech postpone publication of the interim report October 26, 2016 08:25 (CEST)
- Active Biotech update on laquinimod Development: The U.S, Food and Drug administration rescinds the Special Protocol Assessment for laquinimod September 19, 2016 08:44 (CEST)
- Active Biotech update on laquinimod Development: The U.S, Food and Drug administration rescinds the Special Protocol Assessment for laquinimod September 19, 2016 08:30 (CEST)
- Active Biotech AB Interim report January - June 2016 August 11, 2016 08:35 (CEST)